Evidence map›Paper›PMID 35746524›Full record

ArticleVaccines2022

A Five Year Randomized Controlled Trial to Assess the Efficacy and Antibody Responses to a Commercial and Autogenous Vaccine for the Prevention of Infectious Bovine Keratoconjunctivitis.

Matthew M Hille, Matthew L Spangler, Michael L Clawson, Kelly D Heath, Hiep L X Vu, Rachel E S Rogers, John Dustin Loy

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Detection ofAnimals : an open access journal from MDPI · 2023
    Article
  7. Genotype classification ofFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Matthew M HilleSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, NE 68583-0907, USA.
Matthew L SpanglerDepartment of Animal Science, University of Nebraska, Lincoln, NE 68583-0908, USA.ORCID 0000-0001-5184-501X
Michael L ClawsonUnited States Meat Animal Research Center, Clay Center, NE 68933, USA.ORCID 0000-0002-3355-5390
Kelly D HeathSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, NE 68583-0907, USA.
Hiep L X VuDepartment of Animal Science, University of Nebraska, Lincoln, NE 68583-0908, USA.ORCID 0000-0001-8084-4358
Rachel E S RogersDepartment of Statistics, University of Nebraska, Lincoln, NE 68583-0963, USA.ORCID 0000-0002-4145-9630
John Dustin LoySchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, NE 68583-0907, USA.ORCID 0000-0002-7282-096X
University of Nebraska–Lincoln · USRoman L. Hruska U.S. Meat Animal Research Center · US

Funding

United States Department of Agriculture 1002196, 1007070 and 1017646
6 · The paper itself

Abstract

A randomized control trial was performed over a five-year period to assess the efficacy and antibody response induced by autogenous and commercial vaccine formulations against infectious bovine keratoconjunctivitis (IBK). Calves were randomly assigned each year to one of three arms: an autogenous vaccine treatment that included

Indexed as

bovine pinkeyeinfectious bovine keratoconjunctivitisMoraxella bovisMoraxella bovoculiMycoplasma bovoculivaccine

Identifiers

PMID35746524
PMCPMC9228096
OpenAlexW4282595456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.